Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C

BACKGROUND: Limited data exist about effective regimens for pharmacological thromboprophylaxis in children with acute coronavirus disease 2019 (COVID‐19) and multisystem inflammatory syndrome in children (MIS‐C). OBJECTIVES: Study the outcomes of institutional thromboprophylaxis protocol for primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitz, Anna H., Wood, Kelly E., Burghardt, Elliot L., Koestner, Bryan P., Wendt, Linder H., Badheka, Aditya V., Sharathkumar, Anjali A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357887/
https://www.ncbi.nlm.nih.gov/pubmed/35949885
http://dx.doi.org/10.1002/rth2.12780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357887/
https://www.ncbi.nlm.nih.gov/pubmed/35949885
http://dx.doi.org/10.1002/rth2.12780

Ejemplares similares